Lomotil Oral Tablet 2.5-0.025Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Lomotil: Oral tablet (2.5-0.025mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_7411.JPG
Lonox 0.025mg-2.5mg Tab
Sandoz Inc
Pill Identification: GG 4 
Drug Image file DrugItem_5370.JPG
Lomotil Tab
Pfizer US Pharmaceuticals
Pill Identification: 61  |  SEARLE
Drug Image file DrugItem_12245.JPG
Lomotil Tab
PD-RX Pharmaceuticals
Pill Identification: 61  |  SEARLE
Drug Image file DrugItem_11635.JPG
Diphenox/Atrop 2.5-0.025mg Tab
PD-RX Pharmaceuticals Incorporated
Pill Identification: M 15 
Drug Image file DrugItem_1851.JPG
Diphenox/Atrop 2.5-0.025mg Tab
Par Pharmaceutical Inc
Pill Identification: P 771 
Drug Image file DrugItem_4617.JPG
Diphenox/Atrop 2.5-0.025mg Tab
Ivax Pharmaceuticals Inc a Division of Teva USA
Pill Identification: 3966 
Drug Image file DrugItem_1108.JPG
Diphenox/Atrop 2.5-0.025mg Tab
Mylan Pharmaceuticals Inc
Pill Identification: M 15 
Drug Image file DrugItem_12465.JPG
Diphenox/Atrop 2.5-0.025mg Tab
PD-RX Pharmaceuticals
Pill Identification: M 15 
Drug Image file DrugItem_17158.JPG
Diphenox/Atrop 2.5-0.025mg Tab
Greenstone Ltd
Pill Identification: SEARLE  |  61
Drug Image file DrugItem_2627.JPG
Diphenox/Atrop 2.5-0.025mg Tab
Mylan Institutional LLC formerly UDL Laboratories Inc
Pill Identification: M 15 

What is this Medicine?

ATROPINE; DIPHENOXYLATE (A troe peen dye fen OX i late) is used to treat diarrhea.

In-Depth Information
Select a Medication

Lomotil 2.5mg-0.025mg Tablet

NDC: 000250061
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Diarrhea

Storage Information
Storage information not listed
Lomotil 2.5mg-0.025mg Tablet
Drug Image file DrugItem_5370.JPG
Pfizer US Pharmaceuticals
Pill Identification: 61  |  SEARLE
Shape: round
Color: white

Reported Side Effects for Lomotil 2.5mg-0.025mg Tablet

Headache Incidence:
2.5%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
3.0-7.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0-7.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Lomotil 2.5mg-0.025mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Marijuana and Lomotil 2.5mg-0.025mg Tablet(Atropine Sulfate)
Marijuana and Atropine(Atropine Sulfate)
Do not take Marijuana, Medical and Atropine together without talking to your health care provider. Taking these drugs together might increase the risk of high blood pressure or heart rate, nervousness, palpitations, problems with sleep, severe headache, or other side effects.
Major Lifestyle Interaction
Alcohol and Lomotil 2.5mg-0.025mg Tablet(Diphenoxylate Hydrochloride)
Alcohol and CNS Depressants(Diphenoxylate Hydrochloride)
Avoid alcohol-containing drinks while taking this medicine. Using this drug along with alcohol can lead to serious side effects. You may feel drowsy or more tired when taking these drugs together. Do not drive or operate machinery until you know how this drug affects you, and especially if you are drinking alcohol-containing beverages. If you notice slurred speech, confusion, severe weakness, or difficulty breathing, contact your health care provider immediately.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More